| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1999;100:e85.)
© 1999 American Heart Association, Inc.
Circulation Electronic Pages |
The Department of Medicine, University of Queensland, Princess Alexandra Hospital, Brisbane, Australia
| Introduction |
|---|
|
|
|---|
Recently, an analysis was performed using a prospective, longitudinal, population-based sample in which the insertion/deletion (I/D) polymorphism of the ACE gene was postulated as a sex-specific candidate gene for hypertension.1 A significant association between hypertension in males and the ACE DD genotype was observed after adjustment for all confounders (OR 1.59, P=0.02), whereas linkage between the DD genotype and diastolic blood pressure (DBP) in men was significant only when adjusted for age alone (P=0.03 and P=0.16 after and before adjustment for age alone, respectively).
In contrast, an independent prospective, population-based study found
no association between the ACE I/D polymorphism and hypertension,
nor was there any sex stratification with regard to allele or
genotype.2 Adjustment for several potential
confounders did not affect this result for isolated systolic
hypertension (systolic blood pressure [SBP]
160
mm Hg, DBP
90 mm Hg) (II versus DD OR 1.06; I versus D OR
1.09) or systolic-diastolic hypertension (SBP
160 mm Hg, DBP
90 mm Hg) (II versus DD OR 1.19; I
versus D OR 1.16).
O'Donnell et al1 used the Framingham cohort, which has a large sample size (n=3095/1044 sib pairs) and allowed use of both association analyses and pedigree-based linkage analyses, which provides considerable power to the study. The Dubbo cohort subset used by Johnson et al2 is smaller (n=33) but epidemiologically superior, with a sound geographical definition.3
The most obvious differences between these studies are the definition
of high blood pressure and the criteria used to classify patients.
O'Donnell and coworkers1 classified patients as having
hypertension on the basis that they were using antihypertensive
medication or that SBP was
140 mm Hg or DBP
90 mm Hg.
Subjects administered antihypertensive medication were excluded
altogether by Johnson et al2 to avoid misclassification
and to minimize the introduction of serious flaws in the regression of
genotype, whereas subjects with SBP
160 mm Hg would be
classified as normotensive.
The mean age of the Framingham subjects studied was in the mid to late 50s, considerably younger than the Dubbo subset (late 60s). It remains a possibility that the Dubbo cohort signifies an older, progressive representation of the Framingham cohort that has suffered the removal (through premature death) of those subjects with a genetic predisposition to hypertension. The more stringent classification of high blood pressure in the Dubbo cohort, however, would tend to belie this possibility. Certainly, the concerns outlined above render any correlations between the ACE I/D variant and hypertension speculative at the present time.
| References |
|---|
|
|
|---|
2. Johnson AG, Simons LA, Friedlander Y, Simons J, Davis DR, McCallum J. I/D polymorphism of the angiotensin-converting-enzyme gene does not predict isolated systolic hypertension or systolic-diastolic hypertension in the elderly. J Hum Hypertens. 1996;10:167169.[Medline] [Order article via Infotrieve]
3. Simons LA, McCallum J, Simons J, Powell I, Ruys J, Heller R. Dubbo study of the elderly: sociological and cardiovascular risk factors at entry. Aust NZ J Med. 1991;21:701709.[Medline] [Order article via Infotrieve]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |